Global Intravenous Immunoglobulin (IVIg) Sales Market Report 2021

Global Intravenous Immunoglobulin (IVIg) Sales Market Report 2021

Table of Contents
1 Intravenous Immunoglobulin (IVIg) Market Overview
1.1 Intravenous Immunoglobulin (IVIg) Product Scope
1.2 Intravenous Immunoglobulin (IVIg) Segment by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2016 & 2021 & 2027)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) Segment by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Intravenous Immunoglobulin (IVIg) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Intravenous Immunoglobulin (IVIg) Price Trends (2016-2027)
2 Intravenous Immunoglobulin (IVIg) Estimates and Forecasts by Region
2.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
2.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
2.3 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
2.4.2 Europe Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
2.4.3 China Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
2.4.4 Japan Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
2.4.6 India Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
3 Global Intravenous Immunoglobulin (IVIg) Competition Landscape by Players
3.1 Global Top Intravenous Immunoglobulin (IVIg) Players by Sales (2016-2021)
3.2 Global Top Intravenous Immunoglobulin (IVIg) Players by Revenue (2016-2021)
3.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2020)
3.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Company (2016-2021)
3.5 Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Intravenous Immunoglobulin (IVIg) Market Size by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Review by Type (2016-2021)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2021)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2016-2021)
4.2 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2022-2027)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2022-2027)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2022-2027)
5 Global Intravenous Immunoglobulin (IVIg) Market Size by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Review by Application (2016-2021)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2016-2021)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2016-2021)
5.2 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2022-2027)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2022-2027)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2022-2027)
6 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures
6.1 North America Intravenous Immunoglobulin (IVIg) Sales by Company
6.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
6.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
6.2 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
6.2.1 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
6.2.2 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
6.3 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
6.3.1 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2016-2021)
6.3.2 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2022-2027)
7 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures
7.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Company
7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
7.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
7.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
7.3 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)
8 China Intravenous Immunoglobulin (IVIg) Market Facts & Figures
8.1 China Intravenous Immunoglobulin (IVIg) Sales by Company
8.1.1 China Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
8.1.2 China Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
8.2 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
8.2.1 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
8.2.2 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
8.3 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Intravenous Immunoglobulin (IVIg) Market Facts & Figures
9.1 Japan Intravenous Immunoglobulin (IVIg) Sales by Company
9.1.1 Japan Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
9.1.2 Japan Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
9.2 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
9.2.1 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
9.3 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Intravenous Immunoglobulin (IVIg) Market Facts & Figures
10.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Company
10.1.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
10.1.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
10.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
10.2.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
10.3.1 Southeast Asia K Bottle Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Bottle Sales Breakdown by Application (2022-2027)
11 India Intravenous Immunoglobulin (IVIg) Market Facts & Figures
11.1 India Intravenous Immunoglobulin (IVIg) Sales by Company
11.1.1 India Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
11.1.2 India Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
11.2 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
11.2.1 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
11.2.2 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
11.3 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
11.3.1 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2016-2021)
11.3.2 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Intravenous Immunoglobulin (IVIg) Business
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Business Overview
12.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
12.1.5 Baxter Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Business Overview
12.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Grifols Intravenous Immunoglobulin (IVIg) Products Offered
12.2.5 Grifols Recent Development
12.3 CSL
12.3.1 CSL Corporation Information
12.3.2 CSL Business Overview
12.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Intravenous Immunoglobulin (IVIg) Products Offered
12.3.5 CSL Recent Development
12.4 Octapharma
12.4.1 Octapharma Corporation Information
12.4.2 Octapharma Business Overview
12.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered
12.4.5 Octapharma Recent Development
12.5 Biotest
12.5.1 Biotest Corporation Information
12.5.2 Biotest Business Overview
12.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Biotest Intravenous Immunoglobulin (IVIg) Products Offered
12.5.5 Biotest Recent Development
12.6 Kedrion
12.6.1 Kedrion Corporation Information
12.6.2 Kedrion Business Overview
12.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered
12.6.5 Kedrion Recent Development
12.7 Hualan Bio
12.7.1 Hualan Bio Corporation Information
12.7.2 Hualan Bio Business Overview
12.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered
12.7.5 Hualan Bio Recent Development
12.8 CNBG
12.8.1 CNBG Corporation Information
12.8.2 CNBG Business Overview
12.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CNBG Intravenous Immunoglobulin (IVIg) Products Offered
12.8.5 CNBG Recent Development
12.9 Shanghai RAAS
12.9.1 Shanghai RAAS Corporation Information
12.9.2 Shanghai RAAS Business Overview
12.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered
12.9.5 Shanghai RAAS Recent Development
12.10 CBPO
12.10.1 CBPO Corporation Information
12.10.2 CBPO Business Overview
12.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CBPO Intravenous Immunoglobulin (IVIg) Products Offered
12.10.5 CBPO Recent Development
12.11 LFB Group
12.11.1 LFB Group Corporation Information
12.11.2 LFB Group Business Overview
12.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Products Offered
12.11.5 LFB Group Recent Development
12.12 BPL
12.12.1 BPL Corporation Information
12.12.2 BPL Business Overview
12.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 BPL Intravenous Immunoglobulin (IVIg) Products Offered
12.12.5 BPL Recent Development
12.13 Sichuan Yuanda Shuyang
12.13.1 Sichuan Yuanda Shuyang Corporation Information
12.13.2 Sichuan Yuanda Shuyang Business Overview
12.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Products Offered
12.13.5 Sichuan Yuanda Shuyang Recent Development
13 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
13.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
13.4 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Intravenous Immunoglobulin (IVIg) Distributors List
14.3 Intravenous Immunoglobulin (IVIg) Customers
15 Market Dynamics
15.1 Intravenous Immunoglobulin (IVIg) Market Trends
15.2 Intravenous Immunoglobulin (IVIg) Drivers
15.3 Intravenous Immunoglobulin (IVIg) Market Challenges
15.4 Intravenous Immunoglobulin (IVIg) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Intravenous Immunoglobulin (IVIg) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Intravenous Immunoglobulin (IVIg) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Intravenous Immunoglobulin (IVIg) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Region (2016-2021)
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Region (2016-2021)
Table 8. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Forecast by Region (2022-2027)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Intravenous Immunoglobulin (IVIg) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Key Companies (2016-2021)
Table 13. Global Intravenous Immunoglobulin (IVIg) Sales Share by Company (2016-2021)
Table 14. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Company (2016-2021)
Table 16. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2020)
Table 17. Global Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Company (2016-2021)
Table 18. Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites and Area Served
Table 19. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2016-2021)
Table 22. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2016-2021)
Table 23. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2016-2021)
Table 25. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2022-2027)
Table 26. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2022-2027)
Table 28. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2022-2027)
Table 29. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2016-2021)
Table 30. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2016-2021)
Table 31. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2016-2021)
Table 33. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2022-2027)
Table 34. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2022-2027)
Table 35. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2022-2027)
Table 37. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2022-2027)
Table 38. North America Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 39. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 40. North America Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 42. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 43. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 44. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 45. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 46. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 47. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 48. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 49. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 50. Europe Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 51. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 52. Europe Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 54. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 55. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 56. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 57. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 58. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 59. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 60. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 61. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 62. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 63. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 64. China Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 66. China Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 67. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 68. China Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 69. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 70. China Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 71. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 72. China Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 73. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 74. Japan Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 75. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 76. Japan Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 78. Japan Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 79. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 80. Japan Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 81. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 82. Japan Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 83. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 84. Japan Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 85. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 87. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 91. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 93. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 95. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 97. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 98. India Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 99. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 100. India Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 102. India Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 103. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 104. India Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 105. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 106. India Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 107. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 108. India Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 109. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 110. Baxter Corporation Information
Table 111. Baxter Description and Business Overview
Table 112. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 113. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 114. Baxter Recent Development
Table 115. Grifols Corporation Information
Table 116. Grifols Description and Business Overview
Table 117. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 118. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 119. Grifols Recent Development
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 123. CSL Intravenous Immunoglobulin (IVIg) Product
Table 124. CSL Recent Development
Table 125. Octapharma Corporation Information
Table 126. Octapharma Description and Business Overview
Table 127. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 128. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 129. Octapharma Recent Development
Table 130. Biotest Corporation Information
Table 131. Biotest Description and Business Overview
Table 132. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 133. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 134. Biotest Recent Development
Table 135. Kedrion Corporation Information
Table 136. Kedrion Description and Business Overview
Table 137. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 138. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 139. Kedrion Recent Development
Table 140. Hualan Bio Corporation Information
Table 141. Hualan Bio Description and Business Overview
Table 142. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 143. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 144. Hualan Bio Recent Development
Table 145. CNBG Corporation Information
Table 146. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 147. CNBG Description and Business Overview
Table 148. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 149. CNBG Recent Development
Table 150. Shanghai RAAS Corporation Information
Table 151. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 152. Shanghai RAAS Description and Business Overview
Table 153. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 154. Shanghai RAAS Recent Development
Table 155. CBPO Corporation Information
Table 156. CBPO Description and Business Overview
Table 157. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 158. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 159. CBPO Recent Development
Table 160. LFB Group Corporation Information
Table 161. LFB Group Description and Business Overview
Table 162. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 163. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 164. LFB Group Recent Development
Table 165. BPL Corporation Information
Table 166. BPL Description and Business Overview
Table 167. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 168. BPL Intravenous Immunoglobulin (IVIg) Product
Table 169. BPL Recent Development
Table 170. Sichuan Yuanda Shuyang Corporation Information
Table 171. Sichuan Yuanda Shuyang Description and Business Overview
Table 172. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 173. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table 174. Sichuan Yuanda Shuyang Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Intravenous Immunoglobulin (IVIg) Distributors List
Table 178. Intravenous Immunoglobulin (IVIg) Customers List
Table 179. Intravenous Immunoglobulin (IVIg) Market Trends
Table 180. Intravenous Immunoglobulin (IVIg) Market Drivers
Table 181. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 182. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2021 & 2027
Figure 6. Immunodeficiency Examples
Figure 7. Autoimmune Disease Examples
Figure 8. Acute Infection Examples
Figure 9. Global Intravenous Immunoglobulin (IVIg) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate (2016-2027)
Figure 12. Global Intravenous Immunoglobulin (IVIg) Price Trends Growth Rate (2016-2027) (USD/Bottle)
Figure 13. Global Intravenous Immunoglobul

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs